.
.
.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
.
print
.
.
olczyk was excited that a bit of scheduling serendipity allowed him to work hockey in washington and horse racing in baltimore this week. more than anything, he's happy for the normalcy.
.
yesterday they welcomed the findings of coroner patrick mcgurgan, who criticised the staff caring for mrs cavanagh over a series of missed opportunities.
.
david dodick, md, neurologist, mayo clinic; chairman, american migraine foundation.
., an emerita professor in the department of food science & technology at uc davis.
.
.